Biotech
Shares of Anesiva(ANSV) got a small bump Tuesday after the biopharmaceutical company announced positive top-line results from a phase III trial of Zingo in adults.
Zingo is a powder injected intradermally three minutes before patients undergo IV insertions or blood draws. The 699-patient study met the primary endpoint of a reduction in venous procedural pain, and subsequently Anesiva plans to file a supplemental new-drug application with the Food and Drug Administration in the first quarter of 2008 for the use of Zingo in adults. Positive results for the late-phase adult study were expected as Zingo was already approved in children 3 to 18 years old in August. The company recently announced it will hire a sales force of two sales directors and 15 sales representatives to support the launch of Zingo for pediatric use, as well as a co-promotion collaboration with Sagent Pharmaceuticals. Anesiva shares rose 20 cents, or 3%, to $6.71 in recent trading Tuesday.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet